lazertinib,pemetrexed,amivantamab,osimertinib,carboplatin
janssen,genmab,astrazeneca,yuhan corp
['sclc', 'lcsm,(-blcsm)', 'amivantamab', 'nsclc', 'chrysalis2', 'lazertinib', 'osimertinib']
update on amivantamab lazertinib is it time to routinely test for met ihc in our patients w/ egfr mutant mnsclc who progress on osimertinib? if yes, making sure we obtain sufficient tissue at progression will be essential! #asco23 #chrysalis2 #lcsm 
Thoracic Medical Oncologist, Assistant Professor @MDAndersonNews | Interested in patient education, PROs, personalized care | 🫁#cancer #lcsm | Views are my own